drugset / Trial / NCT01100021

Hemodynamic Study of Avanafil and Two α-Adrenergic Blockers,Doxazosin and Tamsulosin

NCT01100021

Phase 1 Completed 48 enrolled VIVUS LLC
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to see if avanafil causes any changes in blood pressure and pulse rate when taken with doxazosin or tamsulosin.

Timeline

Start
2010-02
Primary completion
2010-03
Completion
2010-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 200 mg
Subject Doxazosin Small molecule 8 mg
Subject Tamsulosin Other / unclassified 0.4 mg

Indications